Zerodol-SP Tablet

Description

Zerodol-SP Tablet is a combination medication designed to provide relief from pain and inflammation. It is commonly used to treat conditions such as muscle pain, joint pain, and postoperative pain. The tablet effectively reduces swelling and discomfort in conditions like rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis.

Salt Composition

• Aceclofenac (100mg)
• Paracetamol (325mg)
• Serratiopeptidase (15mg)

How to Use
Take Zerodol-SP Tablet as prescribed by your doctor, with food or milk to prevent stomach upset. Swallow the tablet whole; do not chew, crush, or break it. Adhere to the recommended dosage and duration as advised by your doctor for the best results.

Uses/Benefits

• Pain Relief: Zerodol-SP Tablet is used for short-term relief from pain, swelling, and inflammation in joints and muscles, especially in conditions like rheumatoid arthritis and osteoarthritis.
• Healing Support: The inclusion of Serratiopeptidase helps promote the healing process by breaking down abnormal proteins at the site of inflammation, speeding up recovery.
• Reduced Inflammation: Aceclofenac and Paracetamol work together to block the release of pain-causing chemical messengers, providing relief from discomfort.

Side Effects
Common side effects include:

• Nausea
• Vomiting
• Stomach pain
• Indigestion
• Heartburn
• Loss of appetite
• Diarrhea
• Dizziness
• Increased liver enzymes
• Drowsiness

If any of these side effects persist or worsen, consult your doctor.

Restrictions

• Alcohol: It is unsafe to consume alcohol with Zerodol-SP Tablet.
• Pregnancy: Zerodol-SP Tablet may not be safe during pregnancy. Consult your doctor to assess potential risks and benefits.
• Breastfeeding: The safety of Zerodol-SP Tablet during breastfeeding is not established. Consult your doctor before use.
• Driving: Zerodol-SP Tablet may cause drowsiness, dizziness, or affect vision, which could impair your ability to drive.
• Kidney Issues: Use with caution in patients with kidney disease. Dose adjustment may be necessary. Not recommended for patients with severe kidney disease.
• Liver Issues: Caution is advised for patients with liver disease. Dose adjustments may be needed, and the tablet is not recommended for those with severe or active liver disease.

Marketed By
Ipca Laboratories Ltd